Phibro Animal Health CFO Damian Finio resigns; Richard Johnson named interim CFO

PHIBRO ANIMAL HEALTH CORP

Damian Finio resigns as CFO effective September 29, 2023.
Richard G. Johnson, former CFO (2002-2020), appointed interim CFO effective September 30, 2023.
Johnson has served as Finance Advisor since 2020 and will assist with transition until a successor is found.
No family relationships or reportable transactions involving Johnson under Item 404(a).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Damian Finio

Chief Financial Officer

PAHC · PHIBRO ANIMAL HEALTH CORP

Effective: 2023-09-29
Successor: Richard G. Johnson
Filed: September 5, 2023, 7:59 PM ET

Damian Finio informed the Company that he will be resigning from his position as Chief Financial Officer of the Company effective September 29, 2023.

Appointed (interim)

Richard G. Johnson

Chief Financial Officer

PAHC · PHIBRO ANIMAL HEALTH CORP

Effective: 2023-09-30
Filed: September 5, 2023, 7:59 PM ET

Richard G. Johnson, the former Chief Financial Officer of the Company, who has been serving as a Finance Advisor to the Company since November 16, 2020, will assume the role of interim Chief Financial Officer until a successor to Mr. Finio is identified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Damian Finio departed as Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.

Action: resigning
Role: Chief Financial Officer

Exact text from the filing

Damian Finio informed the Company that he will be resigning from his position as Chief Financial Officer of the Company effective September 29, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard G. Johnson changed role as Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.

Action: assumed the role of interim Chief Financial Officer
Role: Chief Financial Officer

Exact text from the filing

Richard G. Johnson, the former Chief Financial Officer of the Company, who has been serving as a Finance Advisor to the Company since November 16, 2020, will assume the role of interim Chief Financial Officer until a successor to Mr. Finio is identified.

View on SEC.gov

PHIBRO ANIMAL HEALTH CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-098303

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.